Form 4: Maravai LifeSciences Director Jessica Hopfield Acquires Shares and Restricted Stock Units

Director Jessica Hopfield acquired shares and restricted stock units in Maravai LifeSciences Holdings, Inc.

Summary

• On May 23, 2024, Jessica Hopfield, a director of Maravai LifeSciences Holdings, Inc. (MRVI), acquired 20,645 shares of Class A Common Stock at a price of $10.78 per share.
• Following this transaction, Hopfield directly owns 110,768 shares of Class A Common Stock.
• Hopfield also received restricted stock units that vest in full upon the earlier of one year from the grant date or the date of the 2025 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but it's a single transaction and doesn't provide a comprehensive view of the company's performance.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates